Currax(TM) Pharmaceuticals LLC Announces the Acquisition of Nalpropion Pharmaceuticals, Inc.
Acquisition is expected to realize over $10M in annual synergies
Results in Currax owning the global rights to CONTRAVE®
In connection with this transaction, Currax repaid 25% of its outstanding debt
Currax anticipates revenues in excess of $1... Biopharmaceuticals, Mergers & Acquisitions Currax Pharmaceuticals, Nalpropion Pharmaceuticals, CONTRAVE
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Mergers and Aquisitions | Pharmaceuticals